Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Florence O Bada"'
Autor:
Florence O Bada, Kristen A Stafford, Sophia Osawe, Eleanor Wilson, Nadia A Sam-Agudu, Hegang Chen, Alash'le Abimiku, James D Campbell
Publikováno v:
PLOS Global Public Health, Vol 2, Iss 9, p e0001052 (2022)
The World Health Organization recommends universal vaccination of medically stable infants with Hepatitis B vaccine within 24 hours of birth to prevent mother-to-child transmission of Hepatitis B virus (HBV) infection. However, the proportion of infa
Externí odkaz:
https://doaj.org/article/a03215f7186541bbb15c56bde2f9a226
Autor:
Florence O Bada, Nick Blok, Evaezi Okpokoro, Saswata Dutt, Christopher Akolo, Patrick Dakum, Alash'le Abimiku
Publikováno v:
PLoS ONE, Vol 16, Iss 10, p e0259492 (2021)
[This corrects the article DOI: 10.1371/journal.pone.0241065.].
Externí odkaz:
https://doaj.org/article/26b5ce1efddf41c1b49dc1c2433d749d
Autor:
Babayemi O Olakunde, Daniel A Adeyinka, Olubunmi A Olakunde, Olalekan A Uthman, Florence O Bada, Yvonne A Nartey, Dorcas Obiri-Yeboah, Elijah Paintsil, Echezona E Ezeanolue
Publikováno v:
PLoS ONE, Vol 16, Iss 10, p e0259218 (2021)
BackgroundNigeria has a high burden of hepatitis B virus (HBV) infection, commonly acquired through vertical transmission. However, there is a lack of an efficient surveillance system for monitoring and understanding the epidemiology of HBV among pre
Externí odkaz:
https://doaj.org/article/c47ea2af3c894f0d82e3f382d3afc58b
Autor:
Florence O Bada, Nick Blok, Evaezi Okpokoro, Saswata Dutt, Christopher Akolo, Patrick Dakum, Alash'le Abimiku
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0241065 (2020)
BackgroundGlobally, drug resistant tuberculosis (DR-TB) continues to be a public health threat. Nigeria, which accounts for a significant proportion of the global burden of rifampicin/multi-drug resistant-TB (RR/MDR-TB) had a funding gap of $168 mill
Externí odkaz:
https://doaj.org/article/c9ffcdf2c63b44c987c86273f050e381
Autor:
Florence O. Bada, Evaezi Okpokoro, Nick Blok, Emmanuel Meribole, Saswata Dutt, Patrick Dakum, Alash’le Abimiku, Alice Zwerling, Sandra V. Kik
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Nigeria accounts for a significant proportion of the global drug-resistant tuberculosis (DR-TB) burden, a large proportion of which goes untreated. Different models for managing DR-TB treatment with varying levels of hospitalizati
Externí odkaz:
https://doaj.org/article/3bbb264b2e2c4e619f0f6304ce6c6447
Autor:
Echezona E. Ezeanolue, Elijah Paintsil, Daniel A Adeyinka, Babayemi O Olakunde, Olalekan A. Uthman, Dorcas Obiri-Yeboah, Florence O. Bada, Yvonne Ayerki Nartey, Olubunmi A Olakunde
Publikováno v:
PLoS ONE, Vol 16, Iss 10, p e0259218 (2021)
PLoS ONE, Vol 16, Iss 10 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 10 (2021)
PLoS ONE
Background Nigeria has a high burden of hepatitis B virus (HBV) infection, commonly acquired through vertical transmission. However, there is a lack of an efficient surveillance system for monitoring and understanding the epidemiology of HBV among pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40c9ebb3407b13cdbe99146b62248aed
https://doi.org/10.1371/journal.pone.0259218
https://doi.org/10.1371/journal.pone.0259218
Autor:
Alash'le Abimiku, Christopher Akolo, Evaezi Okpokoro, Saswata Dutt, Nick Blok, Patrick Dakum, Florence O Bada
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 12, p e0241065 (2020)
PLoS ONE, Vol 15, Iss 12, p e0241065 (2020)
Background Globally, drug resistant tuberculosis (DR-TB) continues to be a public health threat. Nigeria, which accounts for a significant proportion of the global burden of rifampicin/multi-drug resistant-TB (RR/MDR-TB) had a funding gap of $168 mil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b507ca05466416ff9b52778d6bfc04c
https://doi.org/10.1371/journal.pone.0241065
https://doi.org/10.1371/journal.pone.0241065